Tissot Adrien, Coatanea Anne-Sophie, Rousseau Olivia, Roux Antoine, Coiffard Benjamin, Demant Xavier, Renaud-Picard Benjamin, Le Pavec Jérôme, Magnan Antoine, Mornex Jean-François, Villeneuve Thomas, Falque Loïc, Salpin Mathilde, Boussaud Véronique, Knoop Christiane, Reynaud-Gaubert Martine, Kessler Romain, Dauriat Gaëlle, Lair David, Foureau Aurore, Blanc François-Xavier, Karakachoff Mathilde, Lemarchand Patricia
Nantes Université, CHU Nantes, INSERM, Service de Pneumologie, L'Institut du Thorax, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France.
Nantes Université, CHU Nantes, Service de Pneumologie, L'Institut du Thorax, Nantes, France.
ERJ Open Res. 2025 May 6;11(3). doi: 10.1183/23120541.00623-2024. eCollection 2025 May.
Lung transplantation is a highly dynamic segment of solid organ transplantation in which gender plays a central role. Our objective was to investigate the causes of outcome differences between women and men all along the lung transplantation pathway.
We used data from the French COhort in Lung Transplantation (COLT) study (12 participating lung transplantation centres). Analyses were performed in three phases: baseline clinical characteristics, peri-transplantation period and post-transplantation follow-up.
Overall, 1710 participants (802 women and 908 men) were included in this study. Women were less likely than men to undergo transplantation (91.6% 95.6%; p=0.001) and waited longer before transplantation (115 73 days; p<0.001). Female gender and pre-transplantation class I anti-human leukocyte antigen antibodies were identified as independent factors associated with longer waiting time duration. Female transplant recipients commonly received lungs from height- and sex-matched donors, despite higher female waiting list mortality and a higher proportion of male donors. Importantly, women with oversized lung transplantation (defined by predicted total lung capacity (pTLC) ratio and weight mismatch) did not have worse survival. The overall post-transplantation survival of female recipients was significantly higher than that of male recipients (65.6% 57.3%; p<0.001), although the prevalence of specific major lung transplantation outcomes did not differ according to gender.
Women waited longer and were less likely to undergo transplantation. Women transplanted with an oversized lung did not have worse survival after transplantation, suggesting that size matching criteria based on pTLC ratio and weight mismatch may be less stringent in this context.
肺移植是实体器官移植中一个极具活力的领域,性别在其中起着核心作用。我们的目的是研究在肺移植全过程中男女结局差异的原因。
我们使用了来自法国肺移植队列(COLT)研究(12个参与肺移植的中心)的数据。分析分三个阶段进行:基线临床特征、移植期和移植后随访。
总体而言,本研究纳入了1710名参与者(802名女性和908名男性)。女性接受移植的可能性低于男性(91.6%对95.6%;p=0.001),且移植前等待时间更长(115对73天;p<0.001)。女性性别和移植前I类抗人白细胞抗原抗体被确定为与更长等待时间相关的独立因素。尽管女性等待名单上的死亡率较高且男性供体比例较高,但女性移植受者通常接受来自身高和性别匹配供体的肺。重要的是,接受超大肺移植(由预测总肺容量(pTLC)比值和体重不匹配定义)的女性生存率并未更差。女性受者的总体移植后生存率显著高于男性受者(65.6%对57.3%;p<0.001),尽管特定主要肺移植结局的发生率在性别上并无差异。
女性等待时间更长且接受移植的可能性更低。接受超大肺移植的女性移植后生存率并未更差,这表明在这种情况下基于pTLC比值和体重不匹配的尺寸匹配标准可能不那么严格。